37 results
424B3
INM
InMed Pharmaceuticals Inc
19 Oct 22
Prospectus supplement
6:10am
Ethics Officer prior to returning to private practice in 2008.
Ms. Grove makes valuable contributions to our Board based on her extensive managerial
424B3
tk2iqzlpow
6 Jul 22
Prospectus supplement
2:43pm
424B5
6vmthpgp6rkrolj3b1c6
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
570kq3j3gf
25 Apr 22
Prospectus supplement
5:02pm
424B3
llmp9ah4eq
7 Apr 22
Prospectus supplement
4:46pm
S-3
euk3l d38tmxq6ou
4 Feb 22
Shelf registration
4:36pm
8-K
EX-99.1
dmid vmsyb
10 Nov 21
InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update
1:08pm
DEF 14A
79tifqy
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-99.1
bt16jk
30 Sep 21
Regulation FD Disclosure
1:30pm
10-K
17s 4eslbi
24 Sep 21
Annual report
7:31am
424B3
k7jlaacmi232oixl8d
22 Jul 21
Prospectus supplement
10:27am